MGIC Investment (MTG)
(Delayed Data from NYSE)
$23.52 USD
-0.04 (-0.17%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $23.54 +0.02 (0.09%) 4:30 PM ET
3-Hold of 5 3
B Value F Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$23.52 USD
-0.04 (-0.17%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $23.54 +0.02 (0.09%) 4:30 PM ET
3-Hold of 5 3
B Value F Growth A Momentum C VGM
Zacks News
Reasons Why Investors Should Retain EverQuote (EVER) Stock Now
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote requests, the solid performance of automotive insurance providers and financial flexibility.
Here's Why Should You Stay Invested in Assurant (AIZ) Stock
by Zacks Equity Research
Strength in Global Lifestyle business, growth in fee-based capital-light businesses and solid capital management poise Assurant (AIZ) well for growth.
Here's Why Investing in MGIC Investment (MTG) is Prudent Now
by Zacks Equity Research
MGIC Investment (MTG) is poised to gain from a favorable loss reserve development, higher consolidated investment portfolio and investment yields and effective capital deployment.
Marsh & McLennan (MMC) Agency Unit Takes Over CS Insurance
by Zacks Equity Research
Marsh & McLennan's (MMC) Marsh McLennan Agency is likely to benefit from enhanced product offerings, thanks to its CS Insurance acquisition.
Should Value Investors Buy Cigna (CI) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
American Equity (AEL) Up 21% in a Year: More Room to Run?
by Zacks Equity Research
A compelling product portfolio, increasing popularity of index products in the market, focus on expansion into new verticals, solid balance sheet and effective capital deployment continue to drive American Equity Investment Life Holding (AEL).
Why You Should Hold on to Prudential Financial (PRU) Stock
by Zacks Equity Research
Prudential Financial (PRU) benefits from its international presence, favorable underwriting results, higher earnings from joint venture investments and effective capital deployment
Arthur J. Gallagher (AJG) Up 17% in a Year: More Room to Run?
by Zacks Equity Research
Strong performing Brokerage and Risk Management segments, strategic buyouts to capitalize on growing markets opportunities, effective capital deployment and upbeat guidance continue to drive Arthur J. Gallagher (AJG).
Regional Management (RM) Taps Indiana, Grows Base to 15th State
by Zacks Equity Research
With the expansion in Indiana, people with limited access to consumer credit are expected to benefit from Regional Management's (RM) secured credit products.
Here's Why You Should Add MetLife (MET) to Your Portfolio Now
by Zacks Equity Research
MetLife (MET) continues to benefit on the back of strong VII driving its margins, varied product launches, direct expense ratio below its targeted level and a strong cash position.
Here's Why Hold Strategy is Appropriate for Radian Group (RDN)
by Zacks Equity Research
Radian Group (RDN) is poised to grow due to well-performing real estate services and valuation products, favorable growth estimates and effective capital deployment.
Is MetLife (MET) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Owl Rock Capital's (ORCC) Portfolio Company Acquires Liberty
by Zacks Equity Research
Owl Rock Capital (ORCC) expects the acquisition to create a premier equipment finance platform, which will be responsible for providing tailored financial solutions for the clients.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is MGIC Investment (MTG) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Assurant (AIZ) Rallies 15% YTD: Can It Retain the Momentum?
by Zacks Equity Research
The well-performing Global Lifestyle business, growth in fee-based capital-light businesses and solid capital management continue to drive Assurant (AIZ).
3 Reasons Why MGIC (MTG) Is a Great Growth Stock
by Zacks Equity Research
MGIC (MTG) possesses solid growth attributes, which could help it handily outperform the market.
Wall Street Analysts Believe MGIC (MTG) Could Rally 32%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for MGIC (MTG) points to a 32.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Should You Retain Brighthouse (BHF) Stock in Your Portfolio?
by Zacks Equity Research
Brighthouse (BHF) is well poised for growth on the back of higher underwriting margin, strong annuity sales, lower expenses and prudent capital deployment.
Reasons to Hold Trupanion (TRUP) Stock in Your Portfolio Now
by Zacks Equity Research
Trupanion (TRUP) is poised to grow on a change in the attitude of pet owners who are focusing on pets' health and well-being in an underpenetrated pet insurance market, product launches and extended operating boundaries.
MGIC Investment (MTG) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote requests, solid performance of automotive insurance providers and sufficient liquidity.
MGIC (MTG) Up 3.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
MGIC (MTG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why You Should Hold on to Prudential Financial (PRU) Stock
by Zacks Equity Research
Prudential Financial (PRU) benefits from favorable underwriting, lower expenses, financial flexibility and cost savings initiatives.
Reasons Why MGIC Investment (MTG) Stock is a Solid Pick Now
by Zacks Equity Research
MGIC Investment (MTG) is poised to gain from a higher investment yield, higher premium yield, decreased ceded premiums and effective capital deployment.